HPHA.DE XETRA
Heidelberg Pharma AG
1W: -8.9%
1M: -5.2%
3M: -9.6%
YTD: -18.7%
1Y: -48.4%
3Y: -32.1%
5Y: -65.6%
€2.35 ($2.62)
-0.01 (-0.42%)
Weekly Expected Move ±5.3%
€2
€2
€2
€2
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$1M
-78.7% ▼
5Y CAGR: -29.7%
Gross Profit
-$2M
-138.9% ▼
Operating Income
-$47M
-93.2% ▼
Net Income
-$42M
-118.1% ▼
EPS (Diluted)
$-0.91
-116.7% ▼
EBITDA
-$45M
-142.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2M | $19M | $10M | $7M | $1M |
| YoY Growth | -79.4% | +958.0% | -46.7% | -30.5% | -78.7% |
| Cost of Revenue | $5M | $5M | $3M | $2M | $3M |
| Gross Profit | -$3M | $14M | $7M | $4M | -$2M |
| Gross Margin | -169.3% | 74.7% | 67.0% | 61.3% | -112.0% |
| R&D Expenses | $19M | $26M | $28M | $22M | $39M |
| SG&A Expenses | $4M | $6M | $5M | $8M | $7M |
| Operating Expenses | $23M | $32M | $28M | $26M | $46M |
| Operating Income | -$26M | -$18M | -$21M | -$25M | -$47M |
| Operating Margin | -1464.8% | -99.0% | -215.1% | -358.6% | -3255.4% |
| Interest Expense | $494K | $840K | $762K | $141K | $5K |
| Income Before Tax | -$26M | -$18M | -$20M | -$19M | -$41M |
| Tax Expense | $494K | $2M | $0 | $0 | $1M |
| Net Income | -$27M | -$20M | -$20M | -$19M | -$42M |
| Net Margin | -1522.0% | -106.4% | -206.4% | -283.0% | -2901.1% |
| EPS (Diluted) | $-0.82 | $-0.53 | $-0.44 | $-0.42 | $-0.91 |
| EBITDA | -$25M | -$16M | -$19M | -$18M | -$45M |
| Shares Outstanding | 33M | 37M | 47M | 47M | 47M |